KP Tissue Balance Sheet Health
Financial Health criteria checks 6/6
KP Tissue has a total shareholder equity of CA$70.7M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$72.9M and CA$2.2M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | CA$70.70m |
| Total liabilities | CA$2.17m |
| Total assets | CA$72.88m |
Recent financial health updates
No updates
Recent updates
KP Tissue (TSE:KPT) Is Paying Out A Dividend Of CA$0.18
Mar 14
KP Tissue's (TSE:KPT) Dividend Will Be CA$0.18
Dec 15KP Tissue (TSE:KPT) Is Due To Pay A Dividend Of CA$0.18
Nov 12KP Tissue (TSE:KPT) Will Pay A Dividend Of CA$0.18
Aug 29KP Tissue (TSE:KPT) Is Paying Out A Dividend Of CA$0.18
Aug 15KP Tissue's (TSE:KPT) Dividend Will Be CA$0.18
May 15KP Tissue (TSE:KPT) Is Due To Pay A Dividend Of CA$0.18
Mar 12KP Tissue (TSE:KPT) Has Affirmed Its Dividend Of CA$0.18
Aug 15KP Tissue (TSE:KPT) Has Re-Affirmed Its Dividend Of CA$0.18
Nov 16KP Tissue (TSE:KPT) Is Due To Pay A Dividend Of CA$0.18
Sep 02Financial Position Analysis
Short Term Liabilities: KPT's short term assets (CA$2.2M) exceed its short term liabilities (CA$2.2M).
Long Term Liabilities: KPT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: KPT is debt free.
Reducing Debt: KPT has not had any debt for past 5 years.
Debt Coverage: KPT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: KPT has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 15:55 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KP Tissue Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hamir Patel | CIBC Capital Markets |
| Frederic Tremblay | Desjardins Securities Inc. |
| Zachary Evershed | National Bank Financial |